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Abstract
Objective To examine factors associated with HIV
infection among transgender women in Cambodia.
Design Cross-sectional study.
Settings HIV high-burden sites including the capital city
and 12 provinces.
Participants This study included 1375 sexually active
transgender women with a mean age of 25.9 years (SD
7.1), recruited by using respondent-driven sampling for
structured questionnaire interviews and rapid finger-prick
HIV testing.
Primary outcome measure HIV infection detected by
using Determine antibody test.
Results HIV prevalence among this population was 5.9%.
After adjustment for other covariates, participants living in
urban areas were twice as likely to be HIV infected as those
living in rural areas. Participants with primary education
were 1.7 times as likely to be infected compared with those
with high school education. HIV infection increased with age;
compared with those aged 18–24 years, the odds of being
HIV infected were twice as high among transgender women
aged 25–34 years and 2.8 times higher among those aged
≥35 years. Self-injection of gender affirming hormones
was associated with a fourfold increase in the odds of HIV
infection. A history of genital sores over the previous 12
months increased the odds of HIV infection by threefold.
Transgender women with stronger feminine identity, dressing
as a woman all the time, were twice as likely to be HIV
infected compared with those who did not dress as a woman
all the time. Having never used online services developed
for transgender women in the past six months was also
associated with higher odds of being HIV infected.
Conclusions Transgender women in Cambodia are at
high risk of HIV. To achieve the goal of eliminating HIV in
Cambodia, effective combination prevention strategies
addressing the above risk factors among transgender
women should be strengthened.

Introduction
Globally, transgender women are at high risk
for HIV infection, and little is known about
the burden of HIV infection and its related

Strengths and limitations of this study
►► This is a rare and the second ever Integrated

Biological and Behavioral Survey among
transgender women—one of the most vulnerable
and understudied populations in Cambodia and
globally.
►► This study covered HIV high-burden sites including
the capital city and 12 provinces, thus providing
more nationally generalisable results.
►► This study identified important risk factors for HIV
infection among transgender women, which require
being addressed in order to reduce HIV infection
among this key population.
►► Limitations of the study included potential bias
of self-reported measures, participant sampling,
the cross-sectional nature of the data that limits
causation inferences and the backward selection of
variables in multivariable analysis.

factors in this population. A 2013 systematic
review showed that the global HIV prevalence among transgender women was 19%,
with low-income and middle-income countries having a slightly lower prevalence of
18% compared with 22% in high-income
countries.1 The probability of being infected
with HIV among transgender women was
approximately 49 times higher than among
the general adult population.1 Epidemiologically, transgender women share some HIV
risk factors with other populations, such as
ulcerative sexually transmitted infections
(STIs),2 3 multiple substance use, victimisation, intimate partner violence,4 unprotected
sex,5 multiple sex partners6 and injecting
drug use.5–7
However, transgender women encounter
additional and unique biological, social,
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cultural, legal and economic issues, which increase their
vulnerability to HIV. Transgender women are marginalised legally and economically through discriminative
legislation and practice, which accelerates their vulnerability to HIV infection by confining their job options
to sex work. Sex work in turn exacerbates their stigmatisation and alienation,8 and further increases their HIV
risk.9 10Stigmatisation and discrimination further increase
the risk of HIV infection by preventing transgender
women from seeking essential health information and
services.11 Depression and low self-esteem, which are
common psychological consequences of stigma, further
weaken the bargaining power for condom use in sexual
relationships, resulting in heightened vulnerability to
HIV infection.5 12–15 Transgender women who have sex
with men often engage in receptive anal intercourse,
which increases their risk of HIV acquisition, compared
with insertive sexual partners.2 Syndemics of illicit drug
use, abuse by family members and mental health often
occur together16 and are often associated with less likelihood of transgender women to use condoms during sex
with commercial partners.17 In addition, the confluence
of arbitrary arrests,18 19 violence,16 20 economic pressures21
and other social problems further aggravates mental
health risks among transgender women, causing them to
engage in risky sexual behaviours.6 17
In Southeast Asia, a systematic review of studies from
Indonesia, Thailand and Vietnam demonstrated that
transgender women are particularly at high HIV risk,
with an estimated HIV prevalence of 26.1%, 12.2% and
6.7%, respectively.1 In Cambodia, up to 2012, transgender women were traditionally included in HIV
prevention programmes targeting men who have sex with
men (MSM). As a result, their unique needs were not
reflected in HIV programmes’ goals.22 There was also a
lack of transgender women-specific data to quantify the
number reached by outreach programmes and services.
In 2012, the first Integrated Biological and Behavioral
Survey (IBBS) that specifically included transgender
women in Cambodia found an HIV prevalence of 4.2%
among this population,22 which was six times higher than
the 0.7% prevalence among the general adult population aged 15–45 years,23 and about twice higher than
the 2.1% among MSM.24 This 2012 study also found that
older age (>35 years), residing in Siem Reap province (a
major tourist site), having sex during or after drug use,
not using a condom during the last anal sex and low
self-esteem were associated with HIV infection among
transgender women.22
Recognising the differences in HIV vulnerability and
prevention needs between transgender women and MSM,
in 2013 the National Center for HIV/AIDS, Dermatology
and STD (NCHADS) separated these two populations
in its revised Standard Operating Procedure known as
Boosted Continuum of Prevention, Care and Treatment
(B-CoPCT).25 Transgender women have since been
considered a distinct at-risk group for HIV surveillance
and programming. The National B-CoPCT approach
2

aims to increase the uptake of HIV testing and counselling and other related services, ensure the quality of
outreach and strengthen service delivery to meet specific
needs of key populations, including transgender women,
in-order to achieve Cambodia’s 3.0 goal (ie, zero new
HIV infection, zero discrimination and zero AIDS-related
deaths) by 2020.
This study was conducted to explore the HIV prevalence and identify risk factors associated with HIV
infection among transgender women in Cambodia. The
study findings will help determine ways in which services
and policies can be tailored for this key population.
Methods
Study design and sites
Between December 2015 and February 2016, a cross-sectional study was conducted in the capital city of Phnom
Penh and 12 provinces, namely Battambang, Banteay
Meanchey, Kampong Cham, Kandal, Koh Kong, Kampong
Chhnang, Kampong Speu, Prey Veng, Preah Sihanouk,
Siem Reap, Svay Rieng and Tbong Khmum. These sites
were purposively selected from the 23 HIV high-burden
operational districts identified by NCHADS.26 27 The
study was a combination of a biological (blood test)
and behavioural (face-to-face interview) survey using
Respondent-Driven Sampling method to reach the target
population.
Sample size and sampling procedures
The sample size calculation was based on an assumption
that HIV prevalence would have changed between the
first and the current IBBS. The minimum sample size
required for this study was 1380, which would result in
sufficient power to detect a priori significant difference
in HIV prevalence, as expressed in the following null and
alternative hypotheses. The hypothesis test was that of
one-sample proportion compared with the null hypothesis.
The null hypothesis (H0): HIV prevalence among transgender women remains constant at 4.2%, similar to that
found in the 2012 IBBS.
The alternative hypothesis (Ha): HIV prevalence among
transgender women has decreased by 1.2% from 4.2% in
2012 to 3.0% in the present IBBS.
The sample size was calculated using the following
formula and assumptions:
n=

p0 q0 (z1−α +z1−β

√

(p1 −p0 )2

p1 q1 2
)
p0 q0

►► P0 = estimated proportion in H0. (In the most recent
survey, HIV prevalence among transgender women
was 4.2% in 2012).
►► P1 = estimated proportion in Ha. (The expected HIV
prevalence among transgender women in the current
study is about 3.0%).
►► Z(1-α)⁄) = significance level at 5% in response to one-sided test (Z score=1.645).
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►► Z(1- β) = power level of 80% (Z score=0.83).
►► Refusal rate of 10%.
►► Design effect is assumed to be one.
This sample size was stratified by study site. Roughly
half of the estimated transgender women in each study
site were recruited. However, in five provinces where the
estimated number of transgender women was <100, all
transgender women were recruited. Potential participants
were included in the study if they (1) were biologically
male at birth and self-identified as a woman or third
gender, (2) were Khmer-speaking, (3) were at least 18
years of age at the time of screening, (4) reported having
had sex with at least one man within the past 12 months
and (5) were able and willing to provide an informed
consent.
Among the 13 study sites, data collection was conducted
in 20 locations (6 locations in Phnom Penh and 14 locations in the remaining provinces). The number of the
selected locations was determined based on the required
sample size in each study site. Our participants, including
the seeds and the people the seeds referred, had to meet
the eligibility criteria. These participants were recruited
from the entire transgender population in the study sites.
However, the initial seeds at each site were recruited
through our implementing partners. First, four ‘seeds’
(two seeds aged 18–24 and two seeds 25 or older) who
were well connected with other transgender women in
each location were selected by outreach workers from
implementing partners (local non-governmental organisations (NGOs)) based in the selected locations. These
seeds had to meet the above-mentioned eligibility criteria
for participation and have an established and large social
network consisting of ≥10 other transgender women in
their given location. Eligibility to participate as a seed
was determined by the leader of the data collection team,
using a paper-based eligibility form.
Second, each seed was given a personal identity
number and enrolled in the study. Third, each seed was
given three coupons and asked to refer three additional
transgender women. US$2 was given to each seed for a
successful referral. Each seed was expected to extend to
3–6 ‘recruitment waves’ in each location. If the initial
seeds did not recruit participants, or if enrolment was
halted because all recruitment chains had ‘dried up’ (ie,
stopped recruiting), additional seeds were selected. In
total, 80 seeds were selected by the outreach workers, and
a total of 1375 transgender women were enrolled in the
study. Referred participants were initially screened by the
data collectors for eligibility.
Data collection training
Data were collected by three teams; each team comprised
one field supervisor, five interviewers, one lab technician
and one counsellor. Lab technicians and counsellors were
from the Municipal or Provincial AIDS and STI Program
of the study sites. Data collection teams were trained
for 3 days on study protocol, research ethics, interview
Chhim S, et al. BMJ Open 2017;7:e015390. doi:10.1136/bmjopen-2016-015390

techniques and data collection procedures provided by
the principal investigators and research coordinators.
Data collection procedures
Biological data collection
To determine HIV prevalence, all participants received
onsite rapid finger-prick testing. Pre-test counselling was
provided by qualified, well-trained counsellors working
for voluntary confidential counselling and testing
(VCCT) centres. Participants could receive their HIV
test result verbally after the questionnaire interview. A
blood sample was obtained from each participant by a
trained laboratory technician through finger-prick and
tested for HIV using Determine test, in keeping with the
national protocol.28 Post-test counselling was provided for
each participant regardless of their HIV test result by the
same counsellor who conducted the pre-test counselling
in accordance with NCHADS HIV testing guidelines.28
Participants who were HIV reactive and did not know their
HIV status were referred by the counsellor for confirmatory testing at the nearest VCCT centre. The quality of
HIV tests was monitored using quality control samples.
Discordant results between the screening and confirmatory tests were investigated to elucidate potential causes
and minimise potential erroneous results. In the case of
human error, individuals performing screening tests were
retrained before resuming their involvement in the study.
After HIV testing, the participant was interviewed by a
well-trained interviewer using a computer-assisted survey
instrument. The questionnaire was set up in Qualtrics, a
web-based application, and run on an Android tablet. HIV
testing and interviews were conducted in the selected 20
locations including drop-in centres, private houses and
offices of implementing partners, depending on participants’ convenience.
Questionnaire development and measures
The questionnaire was developed using standardised
and validated tools adapted from TGIBBS-2012,22 FHI
360’s guideline for Behavioral Surveillance Survey29 and
NCHADS’s Boosted-CoPCT25 to measure key variables
related to the objectives of the study. The questionnaire
was initially drafted in English and translated into Khmer,
the national language of Cambodia. Consultative meetings to improve the draft questionnaire were held with
representatives of transgender women, communities
and NGOs working with transgender women, as well as
researchers and practitioners working on HIV and AIDS
in Cambodia. The questionnaire was pre-tested with 20
transgender women in Phnom Penh and finalised based
on findings.
The questionnaire collected information on socioeconomic characteristics, transgender identity and related
experiences, sexual behaviours and condom use with
different types of sexual partners, HIV/STI screening and
care seeking behaviours, substance use and exposure to
HIV programmes. For details of the questionnaire, please
see online supplementary file 1.
3
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Data analyses
HIV prevalence was calculated by dividing the total
number of participants with HIV reactive test results
with the total number of participants. To examine the
associated factors of HIV infection, we conducted both
bivariate and multivariable analyses. In the bivariate analyses, we compared all characteristics and behavioural
variables of participants with a reactive test result to those
of participants with a non-reactive test result. Among
participants who tested HIV positive, additional analyses
were conducted to assess whether there was a significant
difference in sexual behaviours of those who were aware
of their HIV-positive status and of those who were not. χ2
test or Fisher’s exact test (for an expected cell value of ≤5)
was used for categorical variables, while Student’s t-test
was used for continuous variables. To facilitate the model,
some continuous variables, such as age, were transformed
to categorical variables. A multivariable logistic regression model was constructed to examine independent
factors associated with HIV infection. Variables with a
significance level of p<0.05 in the bivariate analyses were
simultaneously included in the model. Backward elimination method was then used to eliminate variables with the
highest p-value one-by-one from the model. STATA V.12.0
for Windows was used to conduct the data analyses.
Ethical statement
Participation in this study was voluntary, and a written
informed consent was obtained from each study participant after a detailed description of the study objective
and procedures was explained to them. Participants were
informed that they could stop responding to questions
and discontinue their participation at any time. Interviews
were conducted at a private place, and confidentiality was
enhanced by assigning a unique and anonymous code to
each participant. No personal identifiers were contained
in the questionnaires or dataset.
Results
HIV prevalence
Of 1375 participants tested, 81 (5.9%) had an HIV reactive test; of whom, 42 (52%) were not aware of their HIV
status prior to the study. Out of the 39 cases who already
knew their status, 37 (94.9%) were currently on HIV
treatment, with the other two reporting having dropped
out of the treatment.
Socio-demographic characteristics
As shown in table 1, the majority of the participants
(83.4%) were recruited from urban communities; 53.0%
were younger than 25 years and 97.2% had never been
married. More than two-thirds of participants (68.6%)
had completed high school and 9.1% had a higher education. The most common main occupations reported by
the participants were hair dressers/beauticians (35.1%),
labourers/farmers (17.5%) and entertainment workers
4

(14.8%). More than one-third of participants (38.6%)
reported an average monthly income in the past
six months of US$100–199, while 16.5% reported it to be
>US$300. Regarding gender identity, 42.2% identified
themselves as female, while 57.2% identified themselves
as third gender. Almost half (48.0%) of the participants
reported dressing as a woman all the time; 45% ever
used hormone/non-hormone substance; and 14.0% ever
injected hormones.
HIV prevalence was significantly higher among participants living in urban communities compared with
participants living in rural communities (6.5% vs 2.6%,
p=0.02). The HIV prevalence was also significantly
different by age group: 3.0% of participants in the age
group of 18–24 years, 8.2% in 25–34 years, 13.1% in
35–44 years and 11.4% in 45 years or older (p<0.001).
HIV prevalence was also significantly higher among those
who never attended school or dropped out of primary
school compared with those who at least attended high
school or higher (10.4% vs 8.0%, p<0.001). In addition,
HIV prevalence was significantly higher among transgender women who were NGO staff (mainly HIV-focused
NGOs) (20.6%) and those who were unemployed (9.4%)
(p=0.03). HIV prevalence was significantly higher among
transgender women who reported dressing as women
all the time (8.5% vs 3.5%, p=0.001), among those who
ever used female hormones (8.1% vs 4.1%, p=0.02) and
among those who ever injected hormones (9.1% vs 5.2%,
p=0.002). Moreover, HIV prevalence was significantly
higher among transgender women who reported never
using online services developed specifically for MSM or
transgender women, such as Facebook group pages or
various websites (9.5% vs 3.9%, p<0.001).
Sexual behaviours
Sexual behaviours among transgender women with reactive and non-reactive HIV test are shown in table 2. An
overwhelming majority of study participants (87.5%)
reported only having had receptive anal sex in the past 12
months. Of the total, 86.0% reported having had anal sex
with at least one man within the previous three months,
with the median number of male sex partners in the past
three months being three (IQR 1–9). Of those who were
sexually active with men in the past three months, 61.9%
reported having used a condom at last sex with a man.
A total of 94.8% of participants who had anal sex in the
prior three months reported having at least one non-transactional male sex partner within the past three months; of
which, 62.1% reported always using condoms with their
non-transactional male sex partners. Of participants who
had sex in the past three months, 41.8% reported having
sex with at least one man in exchange for money or gift;
of whom 60.0% reported always using condoms with the
partners.
Table 2 also shows that HIV prevalence was significantly
higher among participants who reported having had anal
sex with a man in the past three months (6.5% vs 2.1%,
p=0.02) and among those who reported having had sex
Chhim S, et al. BMJ Open 2017;7:e015390. doi:10.1136/bmjopen-2016-015390
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Table 1 Comparison of socio-demographic, gender identity and hormone use characteristics of transgender women with and
without a reactive HIV test
HIV test result
Total (n=1375)

Reactive (n=81)

Non-reactive (n=1294)

n (%)

n (%)

n (%)

Community type
 Urban

1146 (83.4)

75 (6.5)

1071 (93.5)

 Rural

229 (16.6)

6 (2.6)

223 (97.4)

 18–24

729 (53.0)

22 (3.0)

707 (97.0)

 25–34

503 (36.6)

41 (8.2)

462 (91.8)

 ≥35

143 (10.4)

18 (12.6)

125 (87.4)

7 (0.5)

0 (0.0)

Socio-demographics, gender
identity and hormone use

p Value*
0.02

Age (years)
<0.001

Current marital status
 Married
 Widowed/divorced/separated

7 (100)

18 (1.3)

1 (5.6)

17 (94.4)

1334 (97.2)

78 (5.9)

1256 (94.1)

16 (1.2)

2 (15.4)

11 (84.6)

 Primary (0–6 years)

307 (22.3)

32 (10.4)

275 (89.6)

 High school or higher (>7 years)

1068 (77.7)

49 (4.6)

1019 (95.4)

 Never married
 Refused to answer

0.47

Years of formal education completed
<0.001

Main occupation
 Unemployed

64 (4.7)

6 (9.4)

58 (90.6)

482 (35.1)

24 (5.0)

458 (95.0)

 Office worker

50 (3.6)

3 (6.0)

47 (94.0)

 Labour/farmer

241 (17.5)

15 (6.2)

226 (93.8)

 Seller

149 (10.8)

10 (6.7)

139 (93.3)

 Entertainment worker

203 (14.8)

10 (4.9)

193 (95.1)

 Student

108 (7.9)

1 (0.9)

107 (99.1)

 Non-governmental organisation
staff

34 (2.5)

7 (20.6)

27 (79.4)

 Other

44 (3.2)

5 (11.4)

39 (88.6)

 Hair dresser/beautician

0.03

Monthly income in the past six months (US$)
 <100

351 (25.6)

22 (6.3)

329 (93.7)

 100–199

530 (38.6)

29 (5.5)

501 (94.5)

 200–299

266 (19.3)

19 (7.1)

247 (92.9)

 ≥300

226 (16.5)

11 (4.9)

215 (95.1)

 Female

580 (42.2)

29 (5.0)

551 (95.0)

 Third gender

786 (57.2)

52 (6.6)

734 (93.4)

8 (0.6)

0 (0.0)

8 (100)

 All the time

660 (48.0)

56 (8.5)

604 (91.5)

 Not all the time

715 (52.0)

25 (3.5)

689 (96.5)

 No

1123 (81.7)

58 (5.2)

1065 (94.8)

 Yes
Ever self-injected hormones

252 (18.3)

23 (9.1)

229 (90.9)

0.70

Gender identity (self-identified)

 Uncertain

0.35

Frequency of dressing as a woman
0.001

Ever injected hormones
0.02

Continued
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Table 1 Continued
HIV test result
Socio-demographics, gender
identity and hormone use

Total (n=1375)

Reactive (n=81)

Non-reactive (n=1294)

n (%)

n (%)

n (%)

 No

1358 (98.8)

77 (5.7)

1281 (94.3)

 Yes

17 (1.2)

4 (25.5)

13 (76.5)

p Value*
0.002

Ever shared needles when injecting hormones/beauty substances
 No

1355 (98.5)

78 (5.8)

550 (94.2)

 Yes

20 (3.2)

2 (10.0)

18 (90.0)

0.33

Ever used online services developed for men who have sex with men/transgender (eg, Facebook, website)
 No
 Yes

483 (35.1)
892 (64.9)

46 (9.5)
35 (3.9)

437 (90.5)
857 (96.1)

<0.001

*Χ2 or Fisher’s exact test was used as appropriate.

with at least one man in exchange for money or gift in the
prior three months (8.1% vs 5.4%, p=0.04) compared with
participants who did not report these sexual behaviours.
Sexual behaviours and awareness of HIV status
Among the participants who had HIV reactive tests,
additional analyses were conducted to see if there were
differences in sexual behaviours among those who
self-reported a positive status and those who did not.
Participants who did not report or were unaware of their
positive status were significantly less likely to report using
a condom at last sexual intercourse (52.4% vs 79.0%,
p=0.01). No other significant differences were found.
Sexually transmitted infections
Overall, 14.0% of participants reported having had at least
one STI symptom in the past 12 months. Anal and perianal symptoms were most commonly reported (6.1%).
As shown in table 3, HIV prevalence was significantly
higher among participants who reported having had an
STI symptom compared with that among participants
who did not have an STI symptom in the past 12 months
(11.4% vs 5.0%, p<0.001). HIV prevalence was also significantly higher among participants who reported having
had an ulceration or sore in the genital area in the past
12 months compared with that among participants who
did not have it (15.2% vs 5.6%, p<0.001).
Substance use
As shown in table 5, the majority (75.9%) of participants
reported drinking at least one can of beer or a glass of
wine in the past three months, while 10.1% reported using
amphetamine-type stimulants (Yama, Crystal Ice, Ecstasy)
and 0.9% reported using other drugs (marijuana, heroin)
in the previous 12 months. Of total, 1.5% reported having
injected any illicit drugs in the past three months.
Table 4 also shows that HIV prevalence was significantly higher among participants who did not drink
alcohol when compared with that among participants
who reported drinking at least one can of beer or a glass
of wine in the past three months (8.5% vs 5.1%, p=0.02).
6

Moreover, HIV prevalence was significantly higher among
participants who reported injecting any illicit drugs in the
past three months compared with participants who did
not (15.0% vs 5.8%, p=0.01).
Factors associated with HIV infection
Table 5 presents independent factors associated with HIV
infection in multivariable logistic regression analyses.
After adjustment for other covariates, participants living
in urban areas were twice as likely to be HIV infected as
those living in rural areas (adjusted OR (AOR) 2.7, 95%
CI 1.1 to 6.5). Participants with primary education were
1.7 times as likely to be infected compared with those with
high school education (AOR 1.7, 95% CI 1.0 to 2.9). HIV
infection increased with age; compared with those aged
18–24 years, the odds of being HIV infected were twice as
high among transgender women aged 25–34 years (AOR
2.1, 95% CI 1.2 to 3.6) and 2.8 times higher among those
aged ≥35 years (AOR 2.8, 95% CI 1.3 to 6.1). Self-injection of gender affirming hormones was associated with a
fourfold increase in the odds of HIV infection (AOR 4.4,
95% CI 1.1 to 17.3). A history of genital sores over the
previous 12 months increased the odds of HIV infection
by threefold (AOR 3.0, 95% CI 1.2 to 7.8). Transgender
women with stronger feminine identity, dressing as a
woman all the time, were twice as likely to be HIV infected
compared with those who did not dress as a woman all
the time (AOR 2.1, 95% CI 1.2 to 3.8). Having never used
online services developed for transgender women in the
past six months was also associated with higher odds of
being HIV infected (AOR 1.9, 95% CI 1.2 to 3.2).

Discussion
This study reveals an HIV prevalence of 5.9% among
transgender women in Cambodia. This prevalence was
about 20 times higher than the 0.3% among women
attending antenatal care clinics in 2014 who represent the
general adult population aged 15–45 years,30 and about
2.5 times higher than the 2.3% among MSM in 2014.26
Chhim S, et al. BMJ Open 2017;7:e015390. doi:10.1136/bmjopen-2016-015390
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Table 2 Comparisons of sexual behaviours among transgender women with reactive and non-reactive HIV test
HIV test result
Sexual behaviours

Total (n=1375)

Reactive (n=81)

Non-reactive (n=1294)

n (%)

n (%)

n (%)

Role in anal sex with a man (past 12 months)
 Insertive
29 (2.2)

1 (3.5)

28 (96.5)

1145 (87.5)

72 (6.3)

1073 (93.7)

135 (10.3)

7 (5.2)

128 (94.8)

 Receptive
 Both

p Value*
0.73

Had anal sex with a man (past three months)
 No

192 (14.0)

4 (2.1)

188 (97.9)

 Yes

1183 (86.0)

77 (6.5)

1106 (93.5)

0.02

Number of male sexual partners (past three months)
 <2

512 (37.3)

24 (4.7)

488 (95.3)

 ≥2

861 (62.7)

57 (6.6)

804 (93.4)

0.14

Used a condom at last sex (past three months)
 No

451 (38.1)

27 (6.0)

423 (94.0)

 Yes

732 (61.9)

50 (6.8)

682 (93.2)

0.57

Had anal sex with a man, not in exchange for money or gift (past three months)
 No

61 (5.2)

5 (8.2)

56 (91.8)

 Yes

1122 (94.8)

72 (6.4)

1050 (93.6)

0.37

Number of male sexual partners, not in exchange for money or gift (past three months)
 <2

357 (31.9)

24 (6.7)

333 (93.3)

 ≥2

763 (68.1)

48 (6.3)

715 (93.7)

0.78

Condom use with male sexual partner not in exchange for money or gift (past three months)
 Not always

697 (62.1)

50 (7.2)

647 (92.8)

 Always

425 (37.9)

22 (5.2)

403 (94.8)

0.19

Had anal sex with a man in exchange for money or gift (past three months)
 No

688 (58.2)

37 (5.4)

651 (94.6)

 Yes

495 (41.8)

40 (8.1)

455 (91.9)

0.04

Number of male sexual partners in exchange for money or gift (past three months)
 <2

161 (32.5)

12 (7.5)

149 (92.6)

 ≥2

334 (67.5)

28 (8.4)

306 (91.6)

0.72

Condom use with male sexual partner in exchange for money or gift (past three months)
 Not always
 Always

164 (40.0)
246 (60.0)

12 (7.3)
22 (8.9)

152 (92.7)
224 (91.1)

0.56

*χ2 test or Fisher’s exact test was used as appropriate.

This observed prevalence emphasises that transgender
women in Cambodia are at high risk of HIV and is consistent with global literature regarding the high burden of
HIV among this transgender population.1
Although statistically non-significant (p=0.13), the
prevalence found in this study was higher than the prevalence of 4.2% reported in the smaller (n=891) TGIBBS
conducted in 201222 and was therefore contrary to our
hypothesised expectations of reduction in HIV prevalence
among this population. Recent progress in Cambodia,
where 73% of all estimated HIV-positive people or 93%
of those who have been aware of their positive status
are in care,31 had prompted us to hypothesise the lower
Chhim S, et al. BMJ Open 2017;7:e015390. doi:10.1136/bmjopen-2016-015390

prevalence. Although we have no concrete evidence
regarding the non-significant increase of HIV prevalence,
we suggest that it may be related to the sampling variation
in the two surveys. The previous study recruited participants only from the capital city and five provinces (Phnom
Penh, Battambang, Banteay Meanchey, Kampong Cham,
Siem Reap and Preah Sihanouk),22 whereas our study
expanded to additional eight provinces.
More than half (52%) of those who had HIV reactive tests
reported that they had never learnt about their HIV-positive status before they participated in the study. We believe
that this self-reporting of the HIV status is realistic. Since
we were concerned that those who were already aware of
7
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Table 3 Comparisons of sexually transmitted infection symptoms among transgender women with reactive and non-reactive
HIV test
HIV test result
STI symptoms

Total (n=1375)

Reactive (n=81)

Non-reactive (n=1294)

n (%)

n (%)

n (%)

p Value*

59 (5.0)

1123 (95.0)

<0.001

22 (11.4)

171 (88.6)

Had experienced any STI symptom (past 12 months)
 No
1182 (86.0)
 Yes

193 (14.0)

Ulceration or sores around the genitals (past 12 months)
 No

1329 (96.7)

74 (5.6)

1255 (94.4)

 Yes

46 (3.4)

7 (15.2)

39 (84.8)

<0.001

Swelling around the genitals (past 12 months)
 No

1359 (98.8)

80 (5.9)

1279 (94.1)

 Yes

16 (1.2)

1 (6.3)

15 (93.7)

1.000

Abnormal urethral discharge (past 12 months)
 No

1339 (97.4)

77 (5.8)

1262 (94.2)

 Yes

36 (2.6)

4 (11.1)

32 (88.9)
1218 (94.4)

0.16

STI symptoms around the anus (past 12 months)
 No

1291 (93.9)

73 (5.6)

 Yes

84 (6.1)

8 (9.52)

0.15

76 (90.48)

STI symptoms in the mouth or throat (past 12 months)
 No
 Yes

1336 (97.2)
39 (2.8)

76 (5.7)
5 (12.82)

1260 (94.3)
34 (87.18)

0.07

*χ2 or Fisher’s exact test was used as appropriate.

their HIV status may be unwilling to report their status,
we decided to use well-trained counsellors who all were
from the government’s VCCT centres. These counsellors
had many years of experience in providing VCCT services
and were better equipped to cope with difficult situations.
In Cambodia, we believe people are more likely to trust
their counsellors, as opposed to interviewers. However, as
in all self-reported measures, the potential for response
bias cannot be entirely ruled out.
This study also reports important findings related to
factors associated with HIV infection among transgender
women in Cambodia. First, the HIV prevalence among
transgender women residing in urban communities was
twice as high compared with that among transgender
women living in rural communities. This finding is similar
to that in a previous study that found a higher HIV prevalence in transgender women living in urban areas of Siem
Reap and Phnom Penh compared with that among transgender women living in other provinces.22 Findings from
our study suggest that these differences may not necessarily be attributable to common sexual risk practices.
The mean number of sexual partners (8.4 vs 7.9, p=0.70)
and the mean number of male commercial sexual partners (0.7 vs 0.7, p=0.48) in the past three months among
transgender women living in urban and rural communities were not significantly different. In addition, the rates
of inconsistent condom use with male non-commercial
8

sexual partners in the past three months were also similar
in the two groups (58.0% vs 62%, p=0.32).
Given the failure of sexual risk behaviours to sufficiently account for the difference in HIV prevalence,
these data suggest that a higher HIV prevalence among
sexual partners of transgender women in urban communities may possibly explain the higher probability of
urban transgender women to get infected, although
this may not be stated with certainty. This is particularly relevant given that previous studies among all
transgender women found a higher prevalence of HIV
in urban areas.22 Studies among MSM in Cambodia
have also found a higher prevalence of HIV in urban
areas.24 32 In addition, a recent national sentinel survey
among women attending antenatal care clinics found
that HIV prevalence among women in urban areas was
consistently high,30 implying that HIV prevalence in
urban areas among most populations, who potentially
include transgender women and their partners, is high.
It is also possible that transgender population in urban
communities face unique or additional risks compared
with other members of this population in rural areas,22
which could also contribute to the difference in HIV
prevalence between urban and rural communities. Still,
it is possible that those who knew they were positive may
have moved to urban centres for care and treatment,
which unfortunately cannot be examined further in this
Chhim S, et al. BMJ Open 2017;7:e015390. doi:10.1136/bmjopen-2016-015390
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Table 4 Comparisons of substance use among transgender women with reactive and non-reactive HIV test
HIV test result
Substance use

Total (n=1375)

Reactive (n=81)

Non-reactive (n=1294)

n (%)

n (%)

n (%)

Drank at least one can of beer or glass of wine in the past three months
 No
331 (24.1)
28 (8.5)
 Yes

1042 (75.9)

53 (5.1)

303 (91.5)

p Value*
0.02

989 (94.9)

Frequency of having more than five drinks in 1 day in the past three months
 Never more than five drinks

336 (24.4)

28 (8.3)

308 (91.7)

 Less than once a month

771 (56.1)

40 (5.2)

731 (94.8)

 1–3 times a week

157 (11.4)

9 (5.7)

148 (94.3)

111 (8.1)

4 (3.6)

107 (96.4)

1224 (89.0)

72 (5.9)

1152 (94.1)

139 (10.1)

8 (5.8)

131 (94.2)

12 (0.9)

1 (8.3)

11 (91.7)

 Four or more times a week

0.17

Used illicit drugs in the past 12 months
 Never
 Yes, amphetamine-type stimulant
(Yama, Crystal Ice, Ecstasy)
 Other (marijuana, heroin)

0.74

Injected any illicit drugs in the past three months
 No

1355 (98.6)

78 (5.8)

1277 (94.2)

 Yes

20 (1.5)

3 (15.0)

17 (85.0)

0.01

Had sex during/after using illicit drugs in the past three months
 No
 Yes

1286 (93.5)
89 (6.5)

76 (5.9)
5 (5.6)

1210 (94.1)
84 (94.4)

1.00

*χ2 or Fisher’s exact test was used as appropriate.

cross-sectional study. Further research is needed with
regard to this observation.
Second, HIV prevalence among older transgender
women (≥25 years) was significantly higher compared
with that among their younger counterparts. This finding
is similar to those of previous studies in Cambodia22 and
Thailand.3 A possible explanation is that older transgender women had been exposed to risks for a longer
period of time; the number of their sexual partners
accumulated over time and thus increased cumulative
probability of HIV acquisition.22
Third, our study suggests that more overt feminine
expression (eg, those who dressed as a woman all the
time) was associated with a higher HIV prevalence. A
study in the USA found that transgender women who
disclosed their female gender identity possessed a higher
HIV prevalence.33 In our study, these transgender women
who dressed as a woman all the time had higher numbers
of both male non-commercial (mean=8.1 vs 5.1, p=0.004)
and male commercial sexual partners (mean=3.7 vs 1.6,
p<0.001), compared with those who did not. Making their
female status visible could render more chances to meet
with men. However, it could make them difficult to find a
decent job due to stigmatisation and discrimination, thus
leading them to engage in sex work. This finding is in line
with existing literature showing that transgender women
try to have sex with men—both casual and paid sex—to
Chhim S, et al. BMJ Open 2017;7:e015390. doi:10.1136/bmjopen-2016-015390

prove or validate their female gender identity.34–36 In these
contexts, ‘sex work provides both desired gender affirmation and economic stability, often with greater financial
rewards for sex without a condom’.34 The desire to affirm
their gender identity and attractiveness to men also
incentivises them to engage in casual sex with multiple
partners.15 This sexual behaviour may make them more
prone to HIV infection.
There is a tendency to self-inject gender-affirming
hormones, often with shared needles, among transgender
women in Cambodia.37 This risky practice was associated
with an increased risk of HIV infection, implying that
self-injecting was performed through unsafe means, and
that injecting by a trained health or other professional
might mitigate the likelihood of HIV infection. Although
hormone injection to augment femininity is becoming
more common, it can potentially cause adverse health
effects among transgender women.3 38 A Thai study also
found that transgender women who injected hormone to
make them more feminine had a higher HIV prevalence.3
Fourth, transgender women who completed or
dropped out of primary school had a higher HIV prevalence than those with high school education. This finding
confirms results of the TGIBBS 2012 in Cambodia22 and
other studies6 39 that associated low education with high
HIV prevalence among transgender women. This has
important implications for HIV programmes to ensure
9
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Table 5 Factors associated with HIV infection in multivariate logistic regression model
Variables in the final model

Adjusted OR (95% CI)

p Value

Community type
 Rural

Reference

 Urban

2.7 (1.1 to 6.5)

0.03

 Primary (0–6 years)

1.7 (1.1 to 2.9)

0.04

 High school or higher (≥7)

Reference

Formal education attained

Age (years)
 <25

Reference

 25–34

2.1 (1.2 to 3.6)

0.01

 ≥35

2.6 (1.3 to 5.4)

0.01

Frequency of express and/or dressing as a woman
 Not all the time

Reference

 All the time

2.1 (1.2 to 3.8)

0.01

Ever self-injected hormone
 No

Reference

 Yes

4.4 (1.1 to 17.3)

0.03

Ulcerations or sores in the genital area in the past 12 months
 No

Reference

 Yes

3.0 (1.2 to 7.8)

0.02

Used online services developed for men who have sex with men/transgender in the past six months (eg, Facebook, website)
 No
 Yes

1.9 (1.2 to 3.2)
Reference

0.01

*Variables in the table were the ones that remained statistically significant after several steps of model fitting.

that poorly educated transgender women are reached
with education, information, communication and skills
related to HIV prevention and other health-related
services.
Fifth, transgender women with self-reported STI symptoms (having ulcerations or sores in the genital area in
the past 12 months) had a greater HIV prevalence. This is
in line with existing evidence showing that STIs promote
HIV transmission via a variety of biological mechanisms.40
Transgender women with high rates of STIs, particularly
ulcerative genital diseases, are at high risk of HIV acquisition.2 3
Finally, transgender women who reported never using
online services developed for transgender women or
MSM had an increased risk of HIV infection. Low use
of online services by key populations in Cambodia is
iterated in other studies.41 Non-users of online services,
which tend to provide HIV information, education and
communication, might have riskier sexual behaviours.
Our data suggest that transgender women who did not
use online services had higher numbers of overall male
sexual partners (10.2 vs 6.3, p=0.002) and male commercial sexual partners (0.8 vs 0.6, p=0.001) in the past
three months. Also, they had a higher rate of inconsistent condom use with male commercial sexual partners
in the past three months (48.5% vs 34.4%, p=0.004).
10

Unfortunately, in this study, we did not collect the details
about the type of the online services, which could refer
to dating, health and social services, or another type of
online service. Studies in other settings confirm that
transgender women with multiple sexual partners are
exposed to a riskier level of HIV infection.6 15 This finding
suggests that access to community-based services tailored
to transgender population can reduce their vulnerability
to HIV as demonstrated in other settings.42 Sustaining
and increasing the coverage of internet and peer-led
community-based services for this population is particularly important, given that they are often unable to
access health services due to stigmatisation and discrimination,16 41 even in healthcare settings.18 As in other
settings globally,9 only half of those who were infected
with HIV were aware of their status, demonstrating the
need to intensify HIV testing, including self-testing at the
community level, which transgender women in Cambodia
are willing to use.43 Our study also found that once diagnosed the coverage of antiretroviral therapy was high in
this population.
Limitations of the study
Our study covered only the capital city and 12 provinces, which contain the highest numbers of transgender
Chhim S, et al. BMJ Open 2017;7:e015390. doi:10.1136/bmjopen-2016-015390
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women. Since cities and provinces with fewer transgender women were left out, these results may not be
generalised to all transgender women nationally. Second,
the initial participant seeds were identified and recruited
by outreach workers of community-based organisations,
which could introduce bias towards transgender women
under their programmes, leading to a recruitment
bias. This problem could be exacerbated by outreach
workers interviewing some participants who had received
services from their NGO, which could have induced
the participants’ responses. Third, this study employed
a self-reporting questionnaire on sensitive health and
sexual behaviours, which may have been limited by social
desirability bias. Fourth, although minimal, the monetary incentive given to the participants to recruit seeds
may have affected their genuine motivation to partake
in the study, which could influence their responses.
Fifth, we used the backward selection of variables in the
multivariable analysis. By using this method, we possibly
dropped one or more variables that could be significant
if we kept them until the final model. Finally, as this study
was cross-sectional, it reports associations at a given time
and may not be construed to be reporting causal relationships.

Conclusions
This study demonstrates that HIV prevalence among
transgender women in Cambodia remains persistently
high. With the prevalence rate at 5.9%, higher prevalence
was observed among transgender women who resided
in urban areas, of older age, with low education levels,
with previous genital sores, with a history of self-injected
hormone and those who had never used online services
developed for transgender women or MSM. Therefore, to
eliminate new HIV infections among transgender women,
tailored interventions need to focus on these subpopulations and attendant risk factors.
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